2 Reasons Why Hexo (TSX:HEXO) Is Still a Buy

Hexo Corp (TSX:HEXO) has been tanking since its latest earnings report. Here is why the pot company is still worth considering.

| More on:

Hexo Corp (TSX:HEXO) is testament to how quickly things can change in equity markets in general, and in an industry as volatile as the marijuana industry in particular. Just a few months ago, the firm seemed well positioned to become marijuana royalty. However, a round of disappointing financial results have played a critical role in dragging its stock price down.

Since late April, shares of Hexo are down about 40%. Still, there are several reasons why Hexo may still be worth considering. Let’s remind ourselves of two of these reasons.

A move to increase its production capacity

Many pot companies have been spending small fortunes to increase their production capacity. As sales of marijuana are increasing quickly, only those capable of supplying the market will capture a notable share of the market. Hexo struggled in this area, however, lagging behind many of its competitors in its effort to ramp up its production capacity.

But this problem should be rectified soon. The firm completed the first harvest in its 1 million square feet expansion in early April. This facility is projected to generate about 108,000 kilograms of dried cannabis flower per year.

Further, in a move that reverberated throughout the marijuana sector, Hexo acquired Newstrike Brands Ltd, an Ontario-based pot company. This deal gave Hexo access to additional cultivation space, increasing its total cultivation space to 1.8 million square feet, and its projected annual production capacity to 150,000 kilograms of dried cannabis per year.

The acquisition also extended Hexo’s reach within Canadian territory, and the combined entity has supply agreements with nine provinces.

Hexo managing to increase its production capacity is important since the firm is one of the leading pot companies in Quebec, the second largest Canadian province. Last year, Hexo signed a supply deal with Quebec to provide 200,000 kilograms of cannabis over a five-year period, with Quebec retaining the right for a sixth-year option.

This is the largest provincial supply agreement to date, which means that much of Hexo’s product is tied up to a direct revenue source for the foreseeable future. 

Derivative markets

Hexo has been making noise elsewhere. The firm announced a partnership with beverage maker Molson Coors Brewing in August of last year. The resulting venture is known as Truss Beverages, and its stated purpose is to create cannabis infused beverages.

By way reminder, though recreational uses of pot are now legal in Canada, all this means is that private consumers can purchase dried cannabis legally.

Derivative products — such as cannabis infused beverages and edibles — are still very much illegal. However, that is likely set to change by the end of the year.

These derivative markets are very promising, too, especially due to their higher margins. While the dried cannabis market may suffer from a supply glut eventually, the probability of this happening within derivative markets is much lower. In short, the opportunity is too big to pass up, and Hexo is very well positioned to profit from it.

Although the pot company owns a minority stake in its joint venture with Molson Coors Brewing (about 42.5%), it has a leg up on most of its peers since few have made significant moves to profit from this market.

The bottom line

As icing on the cake, Hexo’s valuation is fairly mild by industry’s standard, with a price-to-future earnings ranging between the mid30s to early 50s depending on various future earnings’ estimates. This, however, compares favourably to that of many of its peers, some of which have P/E ratios well above the 100 mark.

With an increasing production capacity and a solid supply agreement to unload its product, as well as a unique position within the upcoming cannabis-infused beverage market, Hexo still looks like a buy.

Fool contributor Prosper Bakiny owns shares of Hexo Corp. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »